325 related articles for article (PubMed ID: 27304831)
1. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S
PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831
[TBL] [Abstract][Full Text] [Related]
2. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
Siskind D; Hahn M; Correll CU; Fink-Jensen A; Russell AW; Bak N; Broberg BV; Larsen J; Ishøy PL; Vilsbøll T; Knop FK; Kisely S; Ebdrup BH
Diabetes Obes Metab; 2019 Feb; 21(2):293-302. PubMed ID: 30187620
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome.
Zimbron J; Khandaker GM; Toschi C; Jones PB; Fernandez-Egea E
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1353-1365. PubMed ID: 27496573
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
[TBL] [Abstract][Full Text] [Related]
6. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
[TBL] [Abstract][Full Text] [Related]
7. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
[TBL] [Abstract][Full Text] [Related]
9. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
Mukundan A; Faulkner G; Cohn T; Remington G
Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
[TBL] [Abstract][Full Text] [Related]
11. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
Praharaj SK; Jana AK; Goyal N; Sinha VK
Br J Clin Pharmacol; 2011 Mar; 71(3):377-82. PubMed ID: 21284696
[TBL] [Abstract][Full Text] [Related]
12. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.
Chen CH; Huang MC; Kao CF; Lin SK; Kuo PH; Chiu CC; Lu ML
J Clin Psychiatry; 2013 May; 74(5):e424-30. PubMed ID: 23759461
[TBL] [Abstract][Full Text] [Related]
13. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
[TBL] [Abstract][Full Text] [Related]
14. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
15. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
[TBL] [Abstract][Full Text] [Related]
16. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
[TBL] [Abstract][Full Text] [Related]
17. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.
Mayfield K; Siskind D; Winckel K; Russell AW; Kisely S; Smith G; Hollingworth S
J Psychopharmacol; 2016 Mar; 30(3):227-36. PubMed ID: 26801056
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.
Henderson DC; Fan X; Copeland PM; Borba CP; Daley TB; Nguyen DD; Zhang H; Hayden D; Freudenreich O; Cather C; Evins AE; Goff DC
Acta Psychiatr Scand; 2007 Feb; 115(2):101-5. PubMed ID: 17244173
[TBL] [Abstract][Full Text] [Related]
20. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.
Bushe CJ; Bradley AJ; Doshi S; Karagianis J
Int J Clin Pract; 2009 Dec; 63(12):1743-61. PubMed ID: 19840151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
